- Home
- RCKT vs BELFB Comparison
RCKT vs BELFB Comparison
Compare RCKT & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- BELFB
- Stock Information
- Founded
- RCKT 1999
- BELFB 1949
- Country
- RCKT United States
- BELFB United States
- Employees
- RCKT N/A
- BELFB N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- BELFB
- Sector
- RCKT Health Care
- BELFB
- Exchange
- RCKT Nasdaq
- BELFB Nasdaq
- Market Cap
- RCKT 764.5M
- BELFB 865.9M
- IPO Year
- RCKT N/A
- BELFB N/A
- Fundamental
- Price
- RCKT $6.99
- BELFB $72.70
- Analyst Decision
- RCKT Strong Buy
- BELFB Strong Buy
- Analyst Count
- RCKT 10
- BELFB 3
- Target Price
- RCKT $43.90
- BELFB $98.33
- AVG Volume (30 Days)
- RCKT 3.1M
- BELFB 89.4K
- Earning Date
- RCKT 05-08-2025
- BELFB 04-24-2025
- Dividend Yield
- RCKT N/A
- BELFB 0.39%
- EPS Growth
- RCKT N/A
- BELFB N/A
- EPS
- RCKT N/A
- BELFB 3.42
- Revenue
- RCKT N/A
- BELFB $558,940,000.00
- Revenue This Year
- RCKT N/A
- BELFB $22.35
- Revenue Next Year
- RCKT N/A
- BELFB $5.36
- P/E Ratio
- RCKT N/A
- BELFB $21.16
- Revenue Growth
- RCKT N/A
- BELFB N/A
- 52 Week Low
- RCKT $4.55
- BELFB $58.00
- 52 Week High
- RCKT $26.98
- BELFB $92.61
- Technical
- Relative Strength Index (RSI)
- RCKT 48.90
- BELFB 55.05
- Support Level
- RCKT $6.21
- BELFB $67.50
- Resistance Level
- RCKT $8.26
- BELFB $74.29
- Average True Range (ATR)
- RCKT 0.54
- BELFB 3.25
- MACD
- RCKT 0.03
- BELFB 0.87
- Stochastic Oscillator
- RCKT 38.05
- BELFB 84.55
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.